Keyphrases
Quercetin
100%
Polycystic Ovary Syndrome
100%
Clinical Perspective
100%
Evidence-based Review
100%
Base Mechanism
100%
Adjunctive Therapy
33%
Clinical Practice
16%
AMP-activated Protein Kinase
16%
Antioxidant
16%
Insulin Resistance
16%
Scopus Database
16%
Testosterone
16%
Steroidogenesis
16%
Women of Reproductive Age
16%
Infertility
16%
Pregnancy Rate
16%
Lipid Profile
16%
Randomized Clinical Trial
16%
PubMed
16%
Metabolic Disease
16%
Glycemic Control
16%
Potential Gains
16%
Hormonal Therapy
16%
Adiponectin Receptor 1 (AdipoR1)
16%
Management Guidelines
16%
Anti-inflammatory Effect
16%
ProQuest
16%
Luteinizing Hormone
16%
Therapy Control
16%
Evidence-based Medicine
16%
Worksheet
16%
Anovulatory Infertility
16%
Endocrinopathy
16%
Disease Manifestations
16%
Herbal Therapy
16%
Current Management
16%
Phosphatidylinositol 3-kinase Signaling
16%
Fertility Drugs
16%
Pharmacological Strategies
16%
Catabolism
16%
INIS
quercetin
100%
reviews
100%
ovaries
100%
therapy
50%
kinases
33%
receptors
16%
proteins
16%
control
16%
diseases
16%
medicine
16%
management
16%
failures
16%
insulin
16%
lipids
16%
women
16%
pregnancy
16%
nucleation
16%
clinical trials
16%
antioxidants
16%
inflammation
16%
fertility
16%
hormones
16%
testosterone
16%
guidelines
16%
appraisal
16%
luteinizing hormone
16%
amp
16%
modulation
16%
metabolic diseases
16%
oocytes
16%
catabolism
16%
Medicine and Dentistry
Polycystic Ovary Syndrome
100%
Quercetin
100%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
16%
Phosphoinositide 3-Kinase
16%
Antioxidant
16%
Kinase Signaling
16%
Randomized Clinical Trial
16%
Pregnancy Rate
16%
Adjuvant Therapy
16%
Systematic Review
16%
Critical Appraisal
16%
Water-Electrolyte Imbalance
16%
Glycemic Control
16%
Insulin Resistance
16%
Oocyte
16%
Steroidogenesis
16%
Hormone Therapy
16%
Luteinizing Hormone
16%
Endocrine Disease
16%
Evidence-Based Medicine
16%
Antiinflammatory Activity
16%
Adiponectin Receptor
16%
Herbal Therapy
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Quercetin
100%
Ovary Polycystic Disease
100%
Phosphatidylinositol 3 Kinase
16%
Antioxidant
16%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
16%
Insulin Resistance
16%
Randomized Clinical Trial
16%
Antiinflammatory Activity
16%
Hormone Cancer Therapy
16%
Luteinizing Hormone
16%
Endocrine Disease
16%
Nucleation
16%
Adiponectin Receptor
16%
Diseases
16%
Metabolic Disorder
16%